Active Ingredient Tocilizumab

Active Ingredient Details

What is the usage for Tocilizumab?

This medication is used alone or with other medications to treat moderate to severe rheumatoid arthritis in adults. It is also used to treat rheumatoid arthritis in children (such as systemic juvenile idiopathic arthritis-SJIA, polyarticular juvenile idiopathic arthritis-PJIA). It helps to reduce pain and swelling due to rheumatoid arthritis. Tocilizumab may also be used to treat a reaction (Cytokine Release Syndrome-CRS) caused by certain cancer treatments. Tocilizumab belongs to a class of drugs known as Interleukin-6 (IL-6) blockers. It works by blocking IL-6, a substance made by the body that causes swelling (inflammation).

How many products in the NDC database contain Tocilizumab?

The NDC database has 31 products with the active ingredient Tocilizumab. The following table lists all the products that have this active ingredient.

NDC Products with Tocilizumab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0078-1343Proprietary Name: TocilizumabLiquidNovartis Pharmaceuticals CorporationACTIVE
50242-135Proprietary Name: Actemra TocilizumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.ACTIVE
50242-136Proprietary Name: Actemra TocilizumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.ACTIVE
50242-137Proprietary Name: Actemra TocilizumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.ACTIVE
50242-138Proprietary Name: Actemra TocilizumabInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-139Proprietary Name: TocilizumabLiquidGenentech, Inc.ACTIVE
50242-141Proprietary Name: TocilizumabLiquidGenentech, Inc. (ssf)ACTIVE
50242-143Proprietary Name: Actemra Actpen TocilizumabInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
64406-022Proprietary Name: Tofidence TocilizumabInjectionIntravenousBiogen Ma Inc.ACTIVE
64406-023Proprietary Name: Tofidence TocilizumabInjectionIntravenousBiogen Ma Inc.ACTIVE
64406-024Proprietary Name: Tofidence TocilizumabInjectionIntravenousBiogen Ma Inc.ACTIVE
65219-584Proprietary Name: Tyenne Tocilizumab-aazgInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-586Proprietary Name: Tyenne Tocilizumab-aazgInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-590Proprietary Name: Tyenne Tocilizumab-aazgInjection, Solution, ConcentrateIntravenousFresenius Kabi Usa, LlcACTIVE
65219-592Proprietary Name: Tyenne Tocilizumab-aazgInjection, Solution, ConcentrateIntravenousFresenius Kabi Usa, LlcACTIVE
65219-594Proprietary Name: Tyenne Tocilizumab-aazgInjection, Solution, ConcentrateIntravenousFresenius Kabi Usa, LlcACTIVE
67643-7007Proprietary Name: TocilizumabLiquidLonza Biologics, Inc.ACTIVE
67643-7008Proprietary Name: TocilizumabLiquidLonza Biologics, Inc.ACTIVE
71124-0019Proprietary Name: TocilizumabLiquidSamsung Biologics Co., Ltd.ACTIVE
72606-042Proprietary Name: Avtozma TocilizumabInjection, SolutionIntravenousCelltrion Usa, Inc.ACTIVE
72606-043Proprietary Name: Avtozma TocilizumabInjection, SolutionIntravenousCelltrion Usa, Inc.ACTIVE
72606-044Proprietary Name: Avtozma TocilizumabInjection, SolutionIntravenousCelltrion Usa, Inc.ACTIVE
72606-045Proprietary Name: Avtozma TocilizumabInjection, SolutionIntravenousCelltrion Usa, Inc.ACTIVE
72606-048Proprietary Name: Tocilizumab-anoh TocilizumabInjection, Solution, ConcentrateIntravenousCelltrion Usa, Inc.ACTIVE
72606-049Proprietary Name: Tocilizumab-anoh TocilizumabInjection, Solution, ConcentrateIntravenousCelltrion Usa, Inc.ACTIVE
72606-050Proprietary Name: Tocilizumab-anoh TocilizumabInjection, Solution, ConcentrateIntravenousCelltrion Usa, Inc.ACTIVE
72606-051Proprietary Name: Tocilizumab-anoh TocilizumabInjection, Solution, ConcentrateIntravenousCelltrion Usa, Inc.ACTIVE
78206-200Proprietary Name: Tofidence TocilizumabInjectionIntravenousOrganon LlcACTIVE
78206-201Proprietary Name: Tofidence TocilizumabInjectionIntravenousOrganon LlcACTIVE
78206-202Proprietary Name: Tofidence TocilizumabInjectionIntravenousOrganon LlcACTIVE
82143-004Proprietary Name: TocilizumabSolution82143ACTIVE
<